- Home
- RVMD vs XP Comparison
RVMD vs XP Comparison
Compare RVMD & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- XP
- Stock Information
- Founded
- RVMD 2014
- XP 2001
- Country
- RVMD United States
- XP Cayman Islands
- Employees
- RVMD N/A
- XP N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- XP Investment Bankers/Brokers/Service
- Sector
- RVMD Health Care
- XP Finance
- Exchange
- RVMD Nasdaq
- XP Nasdaq
- Market Cap
- RVMD 8.7B
- XP 7.4B
- IPO Year
- RVMD 2020
- XP 2019
- Fundamental
- Price
- RVMD $44.39
- XP $12.12
- Analyst Decision
- RVMD Strong Buy
- XP Buy
- Analyst Count
- RVMD 12
- XP 7
- Target Price
- RVMD $64.67
- XP $23.57
- AVG Volume (30 Days)
- RVMD 2.1M
- XP 8.7M
- Earning Date
- RVMD 11-06-2024
- XP 02-25-2025
- Dividend Yield
- RVMD N/A
- XP 12.05%
- EPS Growth
- RVMD N/A
- XP 19.15
- EPS
- RVMD N/A
- XP 1.46
- Revenue
- RVMD $742,000.00
- XP $2,917,445,096.00
- Revenue This Year
- RVMD N/A
- XP $23.84
- Revenue Next Year
- RVMD $1,855.42
- XP $17.31
- P/E Ratio
- RVMD N/A
- XP $8.32
- Revenue Growth
- RVMD N/A
- XP 18.63
- 52 Week Low
- RVMD $25.93
- XP $11.68
- 52 Week High
- RVMD $62.40
- XP $26.84
- Technical
- Relative Strength Index (RSI)
- RVMD 34.18
- XP 25.54
- Support Level
- RVMD $42.53
- XP $11.83
- Resistance Level
- RVMD $44.22
- XP $12.34
- Average True Range (ATR)
- RVMD 1.59
- XP 0.48
- MACD
- RVMD -0.27
- XP 0.01
- Stochastic Oscillator
- RVMD 28.46
- XP 19.30
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.